US Broker Ratings

Arbutus Biopharma (ABUS) Investor Outlook: Exploring a Potential 14.63% Upside

Arbutus Biopharma Corporation (NASDAQ: ABUS) is making waves in the biotechnology sector with its promising pipeline focused on addressing infectious diseases, particularly chronic Hepatitis B virus (HBV). As a clinical-stage..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Potential 234% Upside with Promising Clinical Pipeline

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, stands at the forefront of developing transformative cell and exosome-based therapeutics. With a focus on addressing unmet medical needs, the company..

Valneva SE (VALN) Stock Analysis: Navigating a 31% Potential Upside in the Biotechnology Sector

Valneva SE (NASDAQ: VALN), a French biotechnology company, is gaining attention for its promising pipeline of vaccines targeting infectious diseases with unmet medical needs. With a market cap of $889.79..

Embecta Corp. (EMBC) Investor Outlook: Uncovering a 21.74% Potential Upside

Embecta Corp. (EMBC), a stalwart in the healthcare sector, is carving out its niche within the medical instruments and supplies industry. Headquartered in Parsippany, New Jersey, this company has a..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Exploring a Promising 115% Upside Potential in Biotech

Tyra Biosciences, Inc. (NASDAQ: TYRA) is capturing investor attention with its significant potential upside of 115.63%, as indicated by recent analyst ratings. This clinical-stage biotechnology company is strategically positioned within..

Pharvaris N.V. (PHVS) Stock Analysis: A Potential 70% Upside in the Biotech Arena

Pharvaris N.V. (PHVS), a biopharmaceutical company headquartered in Zug, Switzerland, is making waves in the healthcare sector with its innovative approach to tackling rare diseases. Specializing in the development of..

Auna SA (AUNA) Stock Analysis: Potential Upside of 89.10% Signals Strong Investment Opportunity

Auna SA (AUNA), a Luxembourg-based healthcare provider with operations extending across Mexico, Peru, and Colombia, is capturing the attention of investors with its promising potential upside of 89.10%. As a..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: 87% Potential Upside Ignites Investor Interest

Taysha Gene Therapies, Inc. (TSHA) is making waves in the biotechnology sector with its impressive potential upside of 87.01%. With an average target price of $9.50, significantly higher than its..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Biotech Innovator with 31% Upside Potential

LENZ Therapeutics, Inc. (NASDAQ: LENZ), a promising player in the biotechnology sector, is drawing significant investor interest with its focus on vision-improving therapies. As a biopharmaceutical company, LENZ is currently..

Weave Communications, Inc. (WEAV) Stock Analysis: Navigating a Potential 85% Upside in the Healthcare Sector

Investors in the healthcare sector may want to keep an eye on Weave Communications, Inc. (NASDAQ: WEAV), a company that has carved out a niche in providing customer experience and..

Immatics N.V. (IMTX) Stock Analysis: Potential 37% Upside in a Promising Biotech Sector

Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company based in Tübingen, Germany, is catching the attention of investors with its promising focus on T cell redirecting immunotherapies for cancer treatment...

Delcath Systems, Inc. (DCTH) Investor Outlook: Assessing a 96.87% Potential Upside in the Healthcare Sector

Delcath Systems, Inc. (NASDAQ: DCTH), a prominent player in the healthcare sector specializing in medical devices, is captivating investor attention with its significant potential upside of nearly 96.87%. Based in..

Collegium Pharmaceutical, Inc. (COLL) Investor Outlook: Exploring a 34.3% Potential Upside

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) stands out in the healthcare sector, particularly in the realm of specialty pharmaceuticals focused on pain management. With a market capitalization of $1.05 billion, this..

Owens & Minor, Inc. (OMI) Investor Outlook: Evaluating a 36.89% Potential Upside Amidst Industry Challenges

Owens & Minor, Inc. (NYSE: OMI), a stalwart in the healthcare sector, finds itself navigating a complex landscape as it seeks to leverage its extensive experience in medical distribution. With..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: A Closer Look at Its Impressive Revenue Growth and Analyst Ratings

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is capturing the attention of investors with its compelling growth story within the healthcare sector. This commercial-stage biopharmaceutical company, specializing in therapies for chronic..

KalVista Pharmaceuticals (KALV) Stock Analysis: A Biotech Innovator with 187% Potential Upside

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is gaining investor attention with its impressive 187.84% potential upside, a figure that stands out in today’s volatile market environment. This Cambridge, Massachusetts-based biopharmaceutical company..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Unveiling a 101.56% Potential Upside in the Biotech Space

For investors with a keen eye on the biotechnology sector, ArriVent BioPharma, Inc. (NASDAQ: AVBP) presents an intriguing opportunity. A clinical-stage company based in Newtown Square, Pennsylvania, ArriVent is focused..

STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth Challenges and Investment Potential

STAAR Surgical Company (NASDAQ: STAA) is a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Lake Forest, California, STAAR Surgical is renowned..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with Strategic Focus in the Medical Devices Sector

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector specializing in medical devices, is currently navigating a series of financial and operational challenges. With a market capitalization..

Nuvation Bio Inc. (NUVB) Stock Analysis: Unpacking the 124.98% Potential Upside in the Biotech Sphere

Nuvation Bio Inc. (NASDAQ: NUVB) is a name that has been capturing attention in the biotechnology sector, driven by its promising therapeutic pipeline and remarkable potential upside. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds